HEALTH● LOWSep 8 · Sep 8, 2026, 11:20 AM
Bristol Myers succeeds in mid-stage trial for CAR-T cell therapy in multiple myeloma
Seeking Alpha Tech · global
Bristol Myers has achieved success in a mid-stage trial for its CAR-T cell therapy, which targets multiple myeloma. This marks progress in the development of treatments for the condition.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH36m agoNo Confirmed Case Of Diphtheria In Enugu — CommissionerChannels TVHEALTH51m agoWhat I learned from my stroke at 26BBC AfriqueHEALTH53m agoFG, Katsina Boosts Emergency Healthcare With 18 Ambulances, Upgraded General HospitalChannels TVHEALTH1h agoNicole Kidman's 59-year-old breakfast: matcha tea, puffed rice, red fruits, and almond milkClarín